These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 11761637)

  • 21. Validation of the MCMI-I Borderline Personality Disorder Scale with a well-defined criterion sample.
    Patrick J
    J Clin Psychol; 1993 Jan; 49(1):28-32. PubMed ID: 8425931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the Personality Disorder Interview for DSM-IV (PDI-IV) and SCID-II borderline personality disorder scales: an item-response theory analysis.
    Huprich SK; Paggeot AV; Samuel DB
    J Pers Assess; 2015; 97(1):13-21. PubMed ID: 25203418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construct validity and prevalence rate of borderline personality disorder among Chinese adolescents.
    Leung SW; Leung F
    J Pers Disord; 2009 Oct; 23(5):494-513. PubMed ID: 19817630
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Theory of mind and emotion regulation difficulties in adolescents with borderline traits.
    Sharp C; Pane H; Ha C; Venta A; Patel AB; Sturek J; Fonagy P
    J Am Acad Child Adolesc Psychiatry; 2011 Jun; 50(6):563-573.e1. PubMed ID: 21621140
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationship of the Borderline Symptom List to DSM-IV borderline personality disorder criteria assessed by semi-structured interview.
    Glenn CR; Weinberg A; Klonsky ED
    Psychopathology; 2009; 42(6):394-8. PubMed ID: 19776670
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Disruptive behaviors in the medical setting and borderline personality.
    Sansone RA; Farukhi S; Wiederman MW
    Int J Psychiatry Med; 2011; 41(4):355-63. PubMed ID: 22238840
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation of the French version of the McLean screening instrument for borderline personality disorder (MSI-BPD) in an adolescent sample.
    Mirkovic B; Speranza M; Cailhol L; Guelfi JD; Perez-Diaz F; Corcos M; Robin M; Pham-Scottez A
    BMC Psychiatry; 2020 May; 20(1):222. PubMed ID: 32398037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Construct validity of the five factor borderline inventory.
    DeShong HL; Lengel GJ; Sauer-Zavala SE; O'Meara M; Mullins-Sweatt SN
    Assessment; 2015 Jun; 22(3):319-31. PubMed ID: 25155158
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulsivity, defensive functioning, and borderline personality disorder.
    van Reekum R; Links PS; Mitton MJ; Fedorov C; Patrick J
    Can J Psychiatry; 1996 Mar; 41(2):81-4. PubMed ID: 8705967
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Linguistic adaptation and validation into Spanish of the Diagnostic Interview for Borderline Personality Disorders-Revised (DIB-R).
    Szerman N; Peris MD; Ruiz A; Ruiz M; Gunderson JG; Rejas J;
    Curr Med Res Opin; 2005 Aug; 21(8):1251-9. PubMed ID: 16083535
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Borderline personality disorder in male and female offenders newly committed to prison.
    Black DW; Gunter T; Allen J; Blum N; Arndt S; Wenman G; Sieleni B
    Compr Psychiatry; 2007; 48(5):400-5. PubMed ID: 17707246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validity of the patient health questionnaire (PHQ-9) as a screening tool for depression amongst Nigerian university students.
    Adewuya AO; Ola BA; Afolabi OO
    J Affect Disord; 2006 Nov; 96(1-2):89-93. PubMed ID: 16857265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Validation of a screening instrument for borderline personality disorder in adolescents and young adults - psychometric properties and association with the patient's self-esteem].
    Henze R; Barth J; Parzer P; Bertsch K; Schmitt R; Lenzen C; Herpertz S; Resch F; Brunner R; Kaess M
    Fortschr Neurol Psychiatr; 2013 Jun; 81(6):324-30. PubMed ID: 23775165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The prevalence of borderline personality among buprenorphine patients.
    Sansone RA; Whitecar P; Wiederman MW
    Int J Psychiatry Med; 2008; 38(2):217-26. PubMed ID: 18724572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discriminant validity of the MMPI for borderline personality disorder.
    Hurt SW; Clarkin JF; Frances A; Abrams R; Hunt H
    J Pers Assess; 1985 Feb; 49(1):56-61. PubMed ID: 3989652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prevalence of cyclothymia in borderline personality disorder.
    Levitt AJ; Joffe RT; Ennis J; MacDonald C; Kutcher SP
    J Clin Psychiatry; 1990 Aug; 51(8):335-9. PubMed ID: 2380158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Borderline personality disorder in adolescents: affective and cognitive features.
    Pinto A; Grapentine WL; Francis G; Picariello CM
    J Am Acad Child Adolesc Psychiatry; 1996 Oct; 35(10):1338-43. PubMed ID: 8885588
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Borderline personality disorder and transsexualism].
    Seikowski K; Gollek S; Harth W; Reinhardt M
    Psychiatr Prax; 2008 Apr; 35(3):135-41. PubMed ID: 17671917
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reliability and validity of a Chinese version of the Diagnostic Interview for Borderlines-Revised.
    Wang L; Yuan C; Qiu J; Gunderson J; Zhang M; Jiang K; Leung F; Zhong J; Xiao Z
    Asia Pac Psychiatry; 2014 Sep; 6(3):326-33. PubMed ID: 24302703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differential diagnosis of borderline in relation to schizophrenic and neurotic depressive disorders].
    Eckert J; Papenhausen R; Biermann-Ratjen EM; Wuchner M
    Psychother Psychosom Med Psychol; 1991 Aug; 41(8):320-7. PubMed ID: 1946904
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.